Cargando…

Potentially Inappropriate Medications Use among Older Adults with Dyslipidaemia

Background: Since older patients with dyslipidemia frequently receive many prescriptions, medication errors are typical and expected in this population. This risk has increased by using potentially inappropriate medications. The 2019 Beers criteria were used in this study to investigate potentially...

Descripción completa

Detalles Bibliográficos
Autores principales: Alwhaibi, Monira, Alkofide, Hadeel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299134/
https://www.ncbi.nlm.nih.gov/pubmed/37373754
http://dx.doi.org/10.3390/jcm12124063
_version_ 1785064288696664064
author Alwhaibi, Monira
Alkofide, Hadeel
author_facet Alwhaibi, Monira
Alkofide, Hadeel
author_sort Alwhaibi, Monira
collection PubMed
description Background: Since older patients with dyslipidemia frequently receive many prescriptions, medication errors are typical and expected in this population. This risk has increased by using potentially inappropriate medications. The 2019 Beers criteria were used in this study to investigate potentially inappropriate medication use among older individuals with dyslipidemia. Methods: A cross-sectional retrospective analysis used data from electronic medical records from an ambulatory-care environment. Patients with dyslipidemia who were older adults (>65 years old) were included. To describe and find potential determinants of potentially inappropriate medication usage, descriptive statistics and logistic regression were employed. Results: This study included 2209 older adults (age ≥ 65) with dyslipidemia. The mean age was 72.1 ± 6.0 years, and the majority of the study sample had hypertension (83.7%) and diabetes (61.7%), and around 80.0% were using polypharmacy. The prevalence of potentially inappropriate medications to be avoided among older adults with dyslipidemia was 48.6%. A high risk of potentially inappropriate medication usage was found in older patients with dyslipidemia who had polypharmacy and comorbid diabetes, ischemic heart disease, and anxiety. Conclusions: This study showed that the number of medications prescribed and the presence of concurrent chronic health conditions are important indicators of the risk of potentially inappropriate medications in ambulatory older patients with dyslipidemia.
format Online
Article
Text
id pubmed-10299134
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102991342023-06-28 Potentially Inappropriate Medications Use among Older Adults with Dyslipidaemia Alwhaibi, Monira Alkofide, Hadeel J Clin Med Article Background: Since older patients with dyslipidemia frequently receive many prescriptions, medication errors are typical and expected in this population. This risk has increased by using potentially inappropriate medications. The 2019 Beers criteria were used in this study to investigate potentially inappropriate medication use among older individuals with dyslipidemia. Methods: A cross-sectional retrospective analysis used data from electronic medical records from an ambulatory-care environment. Patients with dyslipidemia who were older adults (>65 years old) were included. To describe and find potential determinants of potentially inappropriate medication usage, descriptive statistics and logistic regression were employed. Results: This study included 2209 older adults (age ≥ 65) with dyslipidemia. The mean age was 72.1 ± 6.0 years, and the majority of the study sample had hypertension (83.7%) and diabetes (61.7%), and around 80.0% were using polypharmacy. The prevalence of potentially inappropriate medications to be avoided among older adults with dyslipidemia was 48.6%. A high risk of potentially inappropriate medication usage was found in older patients with dyslipidemia who had polypharmacy and comorbid diabetes, ischemic heart disease, and anxiety. Conclusions: This study showed that the number of medications prescribed and the presence of concurrent chronic health conditions are important indicators of the risk of potentially inappropriate medications in ambulatory older patients with dyslipidemia. MDPI 2023-06-15 /pmc/articles/PMC10299134/ /pubmed/37373754 http://dx.doi.org/10.3390/jcm12124063 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Alwhaibi, Monira
Alkofide, Hadeel
Potentially Inappropriate Medications Use among Older Adults with Dyslipidaemia
title Potentially Inappropriate Medications Use among Older Adults with Dyslipidaemia
title_full Potentially Inappropriate Medications Use among Older Adults with Dyslipidaemia
title_fullStr Potentially Inappropriate Medications Use among Older Adults with Dyslipidaemia
title_full_unstemmed Potentially Inappropriate Medications Use among Older Adults with Dyslipidaemia
title_short Potentially Inappropriate Medications Use among Older Adults with Dyslipidaemia
title_sort potentially inappropriate medications use among older adults with dyslipidaemia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299134/
https://www.ncbi.nlm.nih.gov/pubmed/37373754
http://dx.doi.org/10.3390/jcm12124063
work_keys_str_mv AT alwhaibimonira potentiallyinappropriatemedicationsuseamongolderadultswithdyslipidaemia
AT alkofidehadeel potentiallyinappropriatemedicationsuseamongolderadultswithdyslipidaemia